Application of an improved cDNA competition technique to identify prostate cancer-associated gene.
A technique to improve cDNA library screening was developed by using mixed probes derived from two closely related cDNA populations of high-metastatic MAT-LyLu and low-metastatic AT-1 Dunning R3227 rat prostate cancer sublines. The technique required the generation of a cDNA library from each subline followed by polymerase chain reaction (PCR) amplification of the cDNA insert population. The PCR products derived from the first library were radiolabeled and mixed with an excess amount of PCR products from the second library. The mixture and an excess amount of both the lambda and pBluescript DNA were used as a probe to screen the first cDNA library. This mixed probe (designated the competition probe) differentially cross-hybridized with the plaque lift of the screened first cDNA library. Weak radioactive signals indicated the cross-hybridization of cDNA sequences common to the competition probe mixture and the first cDNA library, whereas strong signals implied unhybridized unique or abundant cDNA sequences in the first cDNA library. The reproducibility of this technique was confirmed by showing that the full-length cDNA clones were associated with the phenotype of the screened first cell line. The isolated clones were characterized as rat nucleolar protein, rat mitochondrial genes coding for 16S and 12S rRNAs, and rat tRNAs specific for valine and phenyl-alanine. This result is consistent with the fact that the first cell line, MAT-LyLu, is metabolically more active than are AT-1 cells because of higher gene dosage or amplification of nucleolar and mitochondrial RNA and its associated genes. Another clone which had a strong signal represented a novel gene associated with the MAT-LyLu cancer phenotype.
Rinaldy
A R
AR
University of Tennessee Urologic Research Laboratories, College of Medicine, University of Tennessee, Memphis 38163, USA. ARinaldy@UTMEM1.UTMEM.EDU
Steiner
M S
MS
D000818:Animals; D001483:Base Sequence; D018076:DNA, Complementary / Q000235:genetics*; D004272:DNA, Mitochondrial / Q000235:genetics; D004273:DNA, Neoplasm / Q000235:genetics; D015723:Gene Library; D008297:Male; D015336:Molecular Probe Techniques; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000235:genetics; D009693:Nucleic Acid Hybridization / Q000379:methods; D016133:Polymerase Chain Reaction / Q000379:methods; D011471:Prostatic Neoplasms / Q000737:chemistry / Q000235:genetics*; D012334:RNA, Neoplasm / Q000032:analysis* / Q000302:isolation & purification; D012335:RNA, Ribosomal / Q000235:genetics; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D012360:RNA, Transfer, Phe / Q000235:genetics; D012366:RNA, Transfer, Val / Q000235:genetics; D051381:Rats; D014407:Tumor Cells, Cultured
D018076:DNA, Complementary; D004272:DNA, Mitochondrial; D004273:DNA, Neoplasm; D009687:Nuclear Proteins; D012334:RNA, Neoplasm; D012335:RNA, Ribosomal; D012336:RNA, Ribosomal, 16S; D012360:RNA, Transfer, Phe; D012366:RNA, Transfer, Val; C075526:RNA, ribosomal, 12S